Houston Advanced Research Center has appointed Mary Jane Cunningham as associate director of life sciences & health.
Mary Jane Cunningham comes to HARC from Molecular Mining, where she was director of discoveries. Before her stint at Molecular Mining, Cunningham, was director of pharmacogenomics at now-defunct microarray firm Genometrix, of the Woodlands, Texas.
NuGen Technologies has named Chiron co-founder William Rutter director. The appointment follows Rutter’s participation in a $7.5 million Series C round of venture-capital financing that NuGen secured four weeks ago. The company, which makes nucleic acid and protein-amplification and -detection systems, said the proceeds of the financing would be used to further develop its infrastructure and its products.
CytRx, of Los Angeles, has hired three new senior executives, all from The Kriegsman Group: Ed Umali will become director of operations; David Haen will become director of business development; and Carolyn French will become director of communications.
French’s position at CytRx is on a full-time basis, while Umali and Haen are expected to continue to provide certain services to The Kriegsman Group on a limited basis.
Expression Analysis, a microarray genetics-testing and -analysis company, has named Thomas Goralski laboratory director. Goralski will be responsible for the firm’s lab operations, including improving efficiency, lowering costs, and developing and managing staff. Goralski comes to Expression Analysis from Perlegen Sciences, where he was director of production.
Michael Knable has been named to the board of Psychiatric Genomics, the firm said today. He is executive director of Stanley Medical Research Institute.